Application 076619

Type: ANDA
Sponsor: WEST-WARD PHARMS INT

Application Products#

Product, Drug, Ingredient table
Product	Drug	Ingredient	Form	Strength	Reference drug	Reference standard
001	IFOSFAMIDE	IFOSFAMIDE	INJECTABLE;INJECTION	1GM/20ML (50MG/ML)	No	No
002	IFOSFAMIDE	IFOSFAMIDE	INJECTABLE;INJECTION	3GM/60ML (50MG/ML)	No	No

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A076619-001	IFOSFAMIDE	IFOSFAMIDE	1GM/20ML (50MG/ML)	INJECTABLE / INJECTION	AP		2011-06-29
A076619-002	IFOSFAMIDE	IFOSFAMIDE	3GM/60ML (50MG/ML)	INJECTABLE / INJECTION	AP		2011-06-29

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 2 matching rows.

Application-product, TE code table
Application-product	TE code
A076619-001	AP
A076619-002	AP

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 86 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-09-14 22:38:34	2026-08	A076619-001	IFOSFAMIDE	1GM/20ML (50MG/ML)	INJECTABLE / INJECTION	AP	2011-06-29	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A076619-002	IFOSFAMIDE	3GM/60ML (50MG/ML)	INJECTABLE / INJECTION	AP	2011-06-29	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	A076619-001	IFOSFAMIDE	1GM/20ML (50MG/ML)	INJECTABLE / INJECTION	AP	2011-06-29	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A076619-002	IFOSFAMIDE	3GM/60ML (50MG/ML)	INJECTABLE / INJECTION	AP	2011-06-29	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A076619-001	IFOSFAMIDE	1GM/20ML (50MG/ML)	INJECTABLE / INJECTION	AP	2011-06-29	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A076619-002	IFOSFAMIDE	3GM/60ML (50MG/ML)	INJECTABLE / INJECTION	AP	2011-06-29	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A076619-001	IFOSFAMIDE	1GM/20ML (50MG/ML)	INJECTABLE / INJECTION	AP	2011-06-29	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A076619-002	IFOSFAMIDE	3GM/60ML (50MG/ML)	INJECTABLE / INJECTION	AP	2011-06-29	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A076619-001	IFOSFAMIDE	1GM/20ML (50MG/ML)	INJECTABLE / INJECTION	AP	2011-06-29	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A076619-002	IFOSFAMIDE	3GM/60ML (50MG/ML)	INJECTABLE / INJECTION	AP	2011-06-29	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A076619-001	IFOSFAMIDE	1GM/20ML (50MG/ML)	INJECTABLE / INJECTION	AP	2011-06-29	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A076619-002	IFOSFAMIDE	3GM/60ML (50MG/ML)	INJECTABLE / INJECTION	AP	2011-06-29	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A076619-001	IFOSFAMIDE	1GM/20ML (50MG/ML)	INJECTABLE / INJECTION	AP	2011-06-29	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A076619-002	IFOSFAMIDE	3GM/60ML (50MG/ML)	INJECTABLE / INJECTION	AP	2011-06-29	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A076619-001	IFOSFAMIDE	1GM/20ML (50MG/ML)	INJECTABLE / INJECTION	AP	2011-06-29	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A076619-002	IFOSFAMIDE	3GM/60ML (50MG/ML)	INJECTABLE / INJECTION	AP	2011-06-29	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A076619-001	IFOSFAMIDE	1GM/20ML (50MG/ML)	INJECTABLE / INJECTION	AP	2011-06-29	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A076619-002	IFOSFAMIDE	3GM/60ML (50MG/ML)	INJECTABLE / INJECTION	AP	2011-06-29	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A076619-001	IFOSFAMIDE	1GM/20ML (50MG/ML)	INJECTABLE / INJECTION	AP	2011-06-29	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A076619-002	IFOSFAMIDE	3GM/60ML (50MG/ML)	INJECTABLE / INJECTION	AP	2011-06-29	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A076619-001	IFOSFAMIDE	1GM/20ML (50MG/ML)	INJECTABLE / INJECTION	AP	2011-06-29	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A076619-002	IFOSFAMIDE	3GM/60ML (50MG/ML)	INJECTABLE / INJECTION	AP	2011-06-29	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A076619-001	IFOSFAMIDE	1GM/20ML (50MG/ML)	INJECTABLE / INJECTION	AP	2011-06-29	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A076619-002	IFOSFAMIDE	3GM/60ML (50MG/ML)	INJECTABLE / INJECTION	AP	2011-06-29	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A076619-001	IFOSFAMIDE	1GM/20ML (50MG/ML)	INJECTABLE / INJECTION	AP	2011-06-29	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A076619-002	IFOSFAMIDE	3GM/60ML (50MG/ML)	INJECTABLE / INJECTION	AP	2011-06-29	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A076619-001	IFOSFAMIDE	1GM/20ML (50MG/ML)	INJECTABLE / INJECTION	AP	2011-06-29	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A076619-002	IFOSFAMIDE	3GM/60ML (50MG/ML)	INJECTABLE / INJECTION	AP	2011-06-29	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A076619-001	IFOSFAMIDE	1GM/20ML (50MG/ML)	INJECTABLE / INJECTION	AP	2011-06-29	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A076619-002	IFOSFAMIDE	3GM/60ML (50MG/ML)	INJECTABLE / INJECTION	AP	2011-06-29	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A076619-001	IFOSFAMIDE	1GM/20ML (50MG/ML)	INJECTABLE / INJECTION	AP	2011-06-29	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A076619-002	IFOSFAMIDE	3GM/60ML (50MG/ML)	INJECTABLE / INJECTION	AP	2011-06-29	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A076619-001	IFOSFAMIDE	1GM/20ML (50MG/ML)	INJECTABLE / INJECTION	AP	2011-06-29	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A076619-002	IFOSFAMIDE	3GM/60ML (50MG/ML)	INJECTABLE / INJECTION	AP	2011-06-29	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A076619-001	IFOSFAMIDE	1GM/20ML (50MG/ML)	INJECTABLE / INJECTION	AP	2011-06-29	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A076619-002	IFOSFAMIDE	3GM/60ML (50MG/ML)	INJECTABLE / INJECTION	AP	2011-06-29	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A076619-001	IFOSFAMIDE	1GM/20ML (50MG/ML)	INJECTABLE / INJECTION	AP	2011-06-29	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A076619-002	IFOSFAMIDE	3GM/60ML (50MG/ML)	INJECTABLE / INJECTION	AP	2011-06-29	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A076619-001	IFOSFAMIDE	1GM/20ML (50MG/ML)	INJECTABLE / INJECTION	AP	2011-06-29	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A076619-002	IFOSFAMIDE	3GM/60ML (50MG/ML)	INJECTABLE / INJECTION	AP	2011-06-29	`74a2ff9319b5…`

Observed Orange Book normalized TE history#

Normalized TE history page 3 of 3 · 86 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2022-09-29 23:25 UTC	2022-09	A076619-001	AP	1	`e64feba35796…`
2022-09-29 23:25 UTC	2022-09	A076619-002	AP	1	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	A076619-001	AP	1	`cb3db0bc1861…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	A076619-002	AP	1	`cb3db0bc1861…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	A076619-001	AP	1	`a50c72e98297…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	A076619-002	AP	1	`a50c72e98297…`

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Ifosfamide	IFOSFAMIDE	Hikma Pharmaceuticals USA Inc.	c90ab05f-8fe5-437e-a1c0-8b11ef63291e	2020-06-01	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 076619 application number: ANDA076619 ndc (product): 0143-9531 ndc (product): 0143-9530

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

NDC Listings For This Application#

NDC listings for this application page 1 of 1 · 4 matching rows.

NDC, Name, Nonproprietary name table
NDC	Name	Nonproprietary name	Labeler	Marketing category	Status
0143-9530	Ifosfamide	Ifosfamide	Hikma Pharmaceuticals USA Inc.	ANDA	Current
0143-9530	Ifosfamide	Ifosfamide	West-Ward Pharmaceuticals Corp	ANDA	Current
0143-9531	Ifosfamide	Ifosfamide	Hikma Pharmaceuticals USA Inc.	ANDA	Current
0143-9531	Ifosfamide	Ifosfamide	West-Ward Pharmaceuticals Corp	ANDA	Current